Arthroscopy
0
Pipeline Programs
3
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Fresenius KabiGermany - Bad Homburg
1 programEffects of Shoulder Edema on Intubated Tube in Patients Undergoing Shoulder ArthroscopyN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Eisaifospropofol disodium
Fresenius KabiEffects of Shoulder Edema on Intubated Tube in Patients Undergoing Shoulder Arthroscopy
Clinical Trials (2)
Total enrollment: 208 patients across 2 trials
A Study of AQUAVAN® Injection in the Presence of Pre-Medication in Patients Undergoing Minor Surgical Procedures
Start: Oct 2004Est. completion: Mar 2005168 patients
Phase 3Terminated
NCT02184702Fresenius KabiEffects of Shoulder Edema on Intubated Tube in Patients Undergoing Shoulder Arthroscopy
Effects of Shoulder Edema on Intubated Tube in Patients Undergoing Shoulder Arthroscopy
Start: Jun 2014Est. completion: Jul 201640 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.